88
Participants
Start Date
February 8, 2021
Primary Completion Date
February 27, 2023
Study Completion Date
February 27, 2023
Ambrisentan
Endothelin receptor antagonist
Placebo
Placebo
University Hospital for Infectious Diseases Fran Mihaljevic, Zagreb
Hospital Universitario Virgen de las Nieves, Granada
Hospital Universitario San Cecilio, Granada
General Hopital Zadar, Zadar
Hospital Universitario de Jaén, Jaén
Hospital Universitario Infanta Leonor, Madrid
University Hospital 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital de Emergencias Enfermera Isabel Zendal, Madrid
Hospital Rey Juan Carlos, Móstoles
Complejo Hospitalario de Navarra, Pamplona
Hospital Universitario de Cabueñes, Gijón
Hospital Universitario de Galdakao-Usansolo, Galdakao
Lead Sponsor
Noorik Biopharmaceuticals AG
INDUSTRY